Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03716869 · ClinicalTrials.gov registry record · NA

Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
12,909
Enrollment target

NCT03716869: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT03716869 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 12,909 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (820% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03716869, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
12,909 participants
Enrollment target

Study Summary

The primary goal of the proposed study is to compare the effectiveness of universal school based screening for adolescent major depressive disorder to the current school process of targeted screening based on concerning behavior.

Primary Outcome

Universal 1) Adolescents with PHQ-9 score \>10 or who at any point in the year exhibit behavior concerning for MDD prompting a SAP triage request (PHQ-9 score: min 0, max 27, higher scores=greater depression symptoms), 2) Adolescents identified with MDD by SAP triage, and 3) Adolescents who successfully engage with at least one SAP recommendation. Prior Sept-Nov screening adjusted per school preference. Targeted 1\) Adolescents with behavior concerning for MDD prompting a SAP triage request,

Interventions

  • OTHER Universal Screening Arm

Trial Details

FieldValue
Enrollment Target 12,909 participants
Start Date 2018-11-06
Est. Completion 2021-02-03
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT03716869 record still lists

NCT03716869 is an interventional study that assigns participants to a tested intervention. Its 12,909 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (820% higher).

The record links to 0 conditions, and to 1 intervention - of which Universal Screening Arm is the first listed.

NCT03716869 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03716869 about?

NCT03716869 is a clinical study titled "Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder". The primary goal of the proposed study is to compare the effectiveness of universal school based screening for adolescent major depressive disorder to the current school process of targeted screening based on concerning behavior.

What is the current status of trial NCT03716869?

This trial is currently completed. It is a NA study. The enrollment target is 12,909 participants. The study started on 2018-11-06. Estimated completion is 2021-02-03.

What interventions are being tested in trial NCT03716869?

The interventions under investigation include: Universal Screening Arm (OTHER).

Who is sponsoring clinical trial NCT03716869?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03716869's enrollment target sits among peer trials

12,909 13th of 2000 higher than 1,988 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03586895 · 12,838 participants · NA

    e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide

  • NCT07028398 · 12,990 participants · NA

    CMSL Ambulatory Sensitive Condition Nudge Study 2

  • NCT05991453 · 13,000 participants · NA

    Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

  • NCT07177352 · 13,000 participants · Phase 3

    Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03716869, the US trial registry maintained by the National Library of Medicine. NCT03716869 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.